Emmaus

Business

Emmaus Life Sciences Reports Q3 2022 Financial Results and Provides Business Update

TORRANCE, Calif., Nov. 14, 2022 /PRNewswire/ — Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical firm and chief within the remedy of sickle cell illness, right now reported on its outcomes of operations and monetary situation as of and for the three and 9 months ended September30, 2022 and offered a enterprise replace. Current Highlights “We loved a 3rd straight…